Concepedia

Michael L. Zeckel

ML

7

Publications

678

Citations

7

H-Index

1978

Active since

Affiliations

Eli Lilly (United States)(Current)

Michael L. Zeckel is an author at Eli Lilly (United States) specializing in medicine, pathogenesis, and immunology.

Top concepts

Publications per year

1978–2008

7

Publications

7

Histoplasmosis in the acquired immune deficiency syndrome

L. Joseph Wheat, Thomas G. Slama, Michael L. Zeckel · The American Journal of Medicine · 1985 · 255 citations

, , +8

Daptomycin: a novel agent for Gram-positive infections

Francis P. Tally, Michael L. Zeckel, Margaret Wasilewski et al. · Expert Opinion on Investigational Drugs · 1999 · 205 citations

, , +17

Pharmacodynamics of Oritavancin (LY333328) in a Neutropenic-Mouse Thigh Model of <i>Staphylococcus aureus</i> Infection

C J Boylan, Kristina Campanale, Philip W. Iversen et al. · Antimicrobial Agents and Chemotherapy · 2003 · 78 citations · Full text

In Vitro Activities of LY333328 and Comparative Agents against Nosocomial Gram-Positive Pathogens Collected in a 1997 Global Surveillance Study

Michael L. Zeckel, David A. Preston, Bradley S. Allen · Antimicrobial Agents and Chemotherapy · 2000 · 52 citations

A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: Comparison with a controlled clinical trial*

Arthur P. Wheeler, Jay S. Steingrub, Gregory A. Schmidt et al. · Critical Care Medicine · 2008 · 38 citations

Rows per page

1–5 of 7